Navigation Links
MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:11/3/2008

VALENCIA, Calif., Nov. 3 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, November 10, 2008 at 9:55 AM (EST) at the New York Palace Hotel in New York City.

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of the presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA(TM), which has completed Phase 3 clinical trials, and MKC253, which is currently in phase 1 clinical trials. Both of these investigational products are being evaluated for their safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. MannKind to Present at the UBS Global Life Sciences Conference
2. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
3. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
4. MannKind to Present at the Piper Jaffray Healthcare Conference
5. MannKind to Present at the Wachovia 2008 Healthcare Conference
6. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
8. MannKind Corporation Response to Recent Market Events
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
11. MannKind to Present at the Morgan Stanley Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... approved for trading in the United States ... expected to commence on September 17, 2014 on the ... to trade on the TSX Venture Exchange under its ...
(Date:9/17/2014)... 17 de septiembre de 2014  Cryoport, ... proveedor mundial de soluciones logísticas avanzadas criogénicas ... la vida, anunció hoy la contratación de ... con sede en Rótterdam, Países Bajos, para ... Europa en rápido crecimiento. Según los términos ...
(Date:9/17/2014)... , September 17, 2014 ... mode of action from a truly novel ... MGB Biopharma, a biopharmaceutical company ... announces today that it has secured £4.0m ... lead antibacterial, MGB-BP-3, against a range of ...
(Date:9/17/2014)... Cambridge, MA (PRWEB) September 17, 2014 ... and Safety (ACRES) , a multi-stakeholder non-profit collaborative ... and efficiency in clinical research, today announced Phase ... (SASI). , Amir H. Kalali, ... Quintiles and Arti Bajpai, President, Compliance and Quality ...
Breaking Biology Technology:SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4
... April 30 Dendreon Corporation,(Nasdaq: DNDN ) today announced ... Deutsche Bank 33rd Annual Health Care Conference ... ET, Bank of America Health Care Conference Four ... 11:00 a.m. ET, Rodman & Renshaw 5th Annual Global ...
... 3rd Among US For-Profit Healthcare Companies, EL ... provider of kidney care services, announced it has ... Magazine as one of the Top 125,ranking companies ... awarded to organizations that demonstrate a deep,commitment to ...
... Molecular Quantitative Viral Load Assay, ORANGE COUNTY, ... BEC ) announced today that it has ... virus (HCV) from Siemens Healthcare,Diagnostics. Under the agreement, ... viral load HCV blood test for use on ...
Cached Biology Technology:DaVita Honored for 4th Year as Training Top 125 Recipient 2Beckman Coulter Acquires Rights to Hepatitis C Virus 2
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
(Date:9/17/2014)... very cleverly, some lessons on how to create the ... Shaw, director of the Optical Technology Center at Montana ... the nanoscale, we,ll discover them." , Some of those ... a conference called "The Nature of Light: Light in ... University of Arizona College of Optical Sciences. The conference ...
(Date:9/17/2014)... research from the Copenhagen Centre for Social Evolution and ... theory that birth weight and -length can partially predict ... such as autism and schizophrenia later in life. The ... and subsequent hospital diagnoses for up to 30 years, ... The study is published today in the Proceedings ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3
... Ants, wasps and humans live in highly complex societies. Our ... trying to find the balance between cooperation and conflict. Understanding ... us key insights into the evolution of sociality in animals. ... biologist Floria Mora-Kepfer Uy, looks at colonies of social wasps ...
... , Press conference announcement: Three years after Fukushima: ... dial-in information, Press room information, Attention PIOs: Sending ... information, Press registration information, Hotel information, U.S. visa ... information about the Ocean Sciences Meeting, please see ...
... powered by methanol or hydrogen have been well studied, ... biomass as a fuel because of the lack of ... researchers at the Georgia Institute of Technology have developed ... converts biomass to electricity with assistance from a catalyst ...
Cached Biology News:What cooperation and conflict in an insect's society can teach us about social acceptance 22014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 22014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 32014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 42014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 5Solar-induced hybrid fuel cell produces electricity directly from biomass 2Solar-induced hybrid fuel cell produces electricity directly from biomass 3
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
...
Sheep polyclonal to Quinolone ( Abpromise for all tested applications). Antigen: Norfloxacin(N)conjugated to BSA...
Certified U.S. origin. Bovine Serum:, *Certified U.S. origin. Available raw, nonsterile filtered, or sterile filtered. , , *Sterility tested , , *Low Hemoglobin levels , , *Mycoplasma testing upon...
Biology Products: